Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$175.6B | 5.4 | 10.0% | 4.8% | 15.6% | 51.7% | 9.5% | (2.6%) | 2.1% | |
$785.8B | 6.7 | 63.9% | 56.1% | (1.0%) | 73.9% | 56.6% | (5.7%) | 0.5% | |
$401.2B | 6.0 | 11.6% | 4.6% | 14.6% | 19.9% | 11.2% | (3.1%) | 3.6% | |
$378.3B | 6.1 | 8.3% | 1.8% | 15.2% | 90.3% | 9.9% | (3.4%) | 3.4% | |
$240.9B | 6.2 | 15.4% | N/A | 13.4% | 20.1% | 10.8% | 94.5% | 1.9% | |
$240.5B | 7.1 | 36.5% | 28.7% | 40.9% | 38.4% | 31.6% | (2.7%) | 2.8% | |
$229.6B | 7.2 | 17.7% | 10.8% | 18.7% | 27.3% | 17.5% | (4.9%) | 6.9% | |
$151.5B | 6.2 | 17.8% | 10.0% | 4.8% | 8.7% | 16.9% | (5.4%) | 4.7% | |
$148.5B | 5.1 | 7.4% | 0.0% | (0.6%) | 2.9% | 6.4% | (3.0%) | 3.7% | |
$146.5B | 5.8 | 19.9% | 12.1% | 25.7% | (3.4%) | 18.1% | (4.0%) | 3.2% | |
$124.0B | 5.0 | 11.9% | 6.4% | 20.6% | (53.2%) | 11.5% | (4.8%) | 3.9% |
The Amgen Inc. (AMGN) ROIC is 10.0%, compared to the industry median of (14.8%) and the 5-year historical average of 14.9%.
The Amgen Inc. (AMGN) ROIC minus WACC is 4.8%, compared to the industry median of (8.2%) and the 5-year historical average of 10.2%.
The Amgen Inc. (AMGN) ROE is 51.7%, compared to the industry median of (20.1%) and the 5-year historical average of 113.8%.
The Amgen Inc. (AMGN) ROCE is 9.5%, compared to the industry median of (11.7%) and the 5-year historical average of 12.6%.